屎肠球菌的临床分布及耐药性分析  

Enterococcus faecium: Its Clinical Distribution and Drug Resistance

作　　者：黄海霞[1] 吴庆[1] 陈栎江[1] 吴莲凤[1] 

机构地区：[1]温州医学院附属第一医院检验科,浙江温州325000

出　　处：《中华医院感染学杂志》2009年第8期1011-1012,共2页Chinese Journal of Nosocomiology

摘　　要：目的了解医院屎肠球菌的临床分布及耐药现状,为临床治疗提供参考。方法统计分析2006年6月-2008年5月分离到的519株屎肠球菌的耐药情况。结果分离到的519株屎肠球菌,主要来自于尿液,痰液和粪便标本,分别占34.9%、26.8%和18.3%;标本主要分离于重症监护病房(ICU)、呼吸内科病房和急诊重症监护病房(EICU);屎肠球菌对多种抗菌药物耐药,对万古霉素和替考拉宁的耐药率较低,分别为6.2%和3.2%。结论屎肠球菌可引起临床各类感染,且多药耐药率高,治疗困难,应引起临床重视。OBJECTIVE To investigate the clinical distribution and antibiotic resistance of Enterococcus faecium in our hospital and provide the reference for the clinical treatment. METHODS The statistical method was used to analyze the status of drug resistance of 519 E. faecium strains which were isolated form our hospital from Jun 2006 to May 2008. RESULTS Among 519 isolated E. faeciurn strains, most common sources of specimens were urine （34. 9%）, sputum（26. 8%） and feces （18. 3%）; E. faecium infection mainly distributed at ICU, respiratiory wards and EICU; E. faecium was resistant to multiple antibiotics. The drug-resistant rates to vancomycin and teicoplanin were 6.2% and 3.2%, respectively. CONCLUSIONS E. faecium could cause various infection, and has a high antibiotic resistance which is difficult to treat, we should be paid high clinical attention.

关 键 词：屎肠球菌 抗菌药物 耐药性 

分 类 号：R378[医药卫生—病原生物学]